Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,662,139
in 5 filings, $21.7M under 10b5-1 plans

Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-12 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Restricted Stock Units −7,883 7,883
2022-02-12 LaBrosse Nicole SVP, Chief Financial Officer Exercise or conversion +1,389 7,900
2022-02-12 LaBrosse Nicole SVP, Chief Financial Officer Shares withheld for taxes −506 $34.20 $17K 7,394
2022-02-12 LaBrosse Nicole SVP, Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,389 1,389
2022-02-12 Torley Helen President and CEO Exercise or conversion +32,795 584,639
2022-02-12 Torley Helen President and CEO Shares withheld for taxes −17,266 $34.20 $590K 567,373
2022-02-12 Torley Helen President and CEO Exercise or conversion · Restricted Stock Units −32,795 32,794
2022-02-10 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion +8,133 164,979
2022-02-10 LaBarre Michael J. SVP, Chief Technical Officer Shares withheld for taxes −2,992 $34.94 $105K 161,987
2022-02-10 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Restricted Stock Units −8,133 16,266
2022-02-10 LaBrosse Nicole SVP, Chief Financial Officer Exercise or conversion +2,503 7,536
2022-02-10 LaBrosse Nicole SVP, Chief Financial Officer Shares withheld for taxes −1,025 $34.94 $36K 6,511
2022-02-10 LaBrosse Nicole SVP, Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,503 5,005
2022-02-10 Torley Helen President and CEO Exercise or conversion +31,282 568,442
2022-02-10 Torley Helen President and CEO Shares withheld for taxes −16,598 $34.94 $580K 551,844
2022-02-10 Torley Helen President and CEO Exercise or conversion · Restricted Stock Units −31,282 62,562
2022-01-03 Snyder Mark Howard SVP, General Counsel Grant or award · Option to Purchase Common Stock +83,142 83,142
2022-01-03 Snyder Mark Howard SVP, General Counsel Grant or award · Restricted Stock Unit +30,444 30,444
2021-11-08 Torley Helen President and CEO Exercise or conversion +50,000 $14.66 $733K 587,160
2021-11-08 Torley Helen President and CEO Sale −37,775 $39.62 $1.5M 549,385

Page 47 of 48 · 944 trades